FDA update on gene therapy

FDA update on gene therapy

WASHINGTON - The FDA announced the availability of a draft document entitled "Addendum to the Points to Consider on Human Somatic Cell and Gene Therapy (1991)." The draft addendum will be discussed at the Feb. 29 Biological Response Modifiers Advisory Committee meeting. ...